Kobe, Japan

Yuka Yamaguchi



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yuka Yamaguchi: Innovator in Pharmaceutical Compositions

Introduction

Yuka Yamaguchi is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable formulations for therapeutic proteins. With a total of 3 patents, her work focuses on enhancing the efficacy and marketability of pharmaceutical compositions.

Latest Patents

Yamaguchi's latest patents include innovative formulations aimed at improving the stability of fusion proteins. One notable patent describes a lyophilized preparation that contains a fusion protein comprising an antibody and a lysosomal enzyme. This formulation is designed to be stable enough for market distribution and includes components such as sodium chloride, sucrose, poloxamer, and phosphate buffer. Another patent details an aqueous pharmaceutical composition that maintains stability while containing a fusion protein at specific concentrations, along with sodium chloride, sucrose, a nonionic surfactant, and a buffer, adjusted to a pH of 5.0 to 7.5.

Career Highlights

Yuka Yamaguchi is currently employed at JCR Pharmaceuticals Co., Ltd., where she continues to advance her research in pharmaceutical formulations. Her work has been instrumental in developing products that meet the rigorous standards required for market approval.

Collaborations

Yamaguchi collaborates with notable colleagues, including Hidehito Yasukawa and Shinji Okabe, to further enhance the research and development of innovative pharmaceutical solutions.

Conclusion

Yuka Yamaguchi's contributions to the field of pharmaceuticals through her innovative patents and collaborative efforts highlight her role as a key inventor in the industry. Her work continues to pave the way for advancements in therapeutic formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…